Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2012
07/17/2012CA2498212C Multi-layered hemostatic dressing comprising thrombin and fibrinogen
07/17/2012CA2478478C Coupling hydroxyalkyl starch via a terminal aldehyde group or a functional group derived therefrom, to a protein
07/17/2012CA2476538C Use of erythropoietin for the preventive or curative treatment of cardiac failure
07/17/2012CA2448265C Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents
07/17/2012CA2446201C Improved neuronal gene transfer
07/17/2012CA2402015C Beta 1, 2-xylosyltransferase-gene from arabidopsis
07/17/2012CA2391392C Methods for screening candidate drugs that disrupt mif and jab1 interaction, mif and jab1 complex, antibodies and uses thereof
07/17/2012CA2355976C Vascular endothelial cell growth factor antagonists and uses thereof
07/17/2012CA2322559C Compositions and methods for modulating vascularization
07/17/2012CA2277486C Synthetic antibiotics
07/17/2012CA2266325C A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
07/12/2012WO2012094679A2 Compositions and methods for delivery of high-affinity oxygen binding agents to tumors
07/12/2012WO2012094653A2 Compositions and methods for macromolecular drug delivery
07/12/2012WO2012094512A2 Myocardial tissue targeting peptides
07/12/2012WO2012094297A1 Azuvirin peptides
07/12/2012WO2012094004A1 Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens
07/12/2012WO2012093931A1 Antimicrobial fusion compounds and uses thereof
07/12/2012WO2012093753A1 Artificial saliva comprising hyaluronic acid
07/12/2012WO2012093293A1 Process for preparation of caspofungin acetate and intermediates
07/12/2012WO2012093258A2 Treatment and screening
07/12/2012WO2012093132A1 Plasminogen and plasmin variants
07/12/2012WO2012092760A1 Method for obtaining strains highly expressing lipase and use of lipase obtained
07/12/2012WO2012064697A3 Materials presenting notch signaling molecules to control cell behavior
07/12/2012WO2012062925A3 Compounds and methods for treating pain
07/12/2012WO2012058585A3 Treatment of heart failure with natriuretic peptides
07/12/2012WO2012049430A3 Hydrolysates of animal proteins of marine origin with neuroprotective properties
07/12/2012WO2012048214A9 Use of hyaluronan for promoting angiogenesis
07/12/2012WO2012031023A3 Treatment of inflammatory bowel diseases using a tripeptide
07/12/2012WO2011163228A3 Phage-gnrh constructs, their mimics, antigenic compositions, and sequences for immunocontraception of animals and other applications
07/12/2012WO2011156751A3 Immunogenic vaccine
07/12/2012WO2011152618A4 Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof
07/12/2012WO2011133960A3 Lysosomal storage disease enzyme
07/12/2012WO2011116245A3 Methods of treating inflammation
07/12/2012WO2009073909A8 Cyclic, cystein-free protein
07/12/2012US20120179772 System and method to improve fitness training
07/12/2012US20120179090 Transmucosal delivery of therapeutic agents and methods of use thereof
07/12/2012US20120178917 Rna aptamers and methods for identifying the same
07/12/2012US20120178912 RECEPTOR ACTIVATOR OF NF-kappaB
07/12/2012US20120178792 Drg11-responsive (dragon) gene family
07/12/2012US20120178784 Use Of Inhibitors Of The Renin-Angiotensin System
07/12/2012US20120178703 Multimeric polypeptides of hla-g including at least two alpha3 domains and pharmaceutical uses thereof
07/12/2012US20120178702 Stable lipid-comprising drug delivery complexes and methods for their production
07/12/2012US20120178701 Melanocortin Receptor-Specific Peptides
07/12/2012US20120178700 Peptidomimetic macrocycles
07/12/2012US20120178699 Klotho protein and related compounds for the treatment and diagnosis of cancer
07/12/2012US20120178698 Agents and Uses Thereof
07/12/2012US20120178697 Compositions and methods for the inhibition of dishevelled proteins
07/12/2012US20120178696 Compositions and Methods for Modulating AMPA Receptor-mediated Excitotoxicity
07/12/2012US20120178695 Methods of treating neuropathic pain
07/12/2012US20120178694 Modified Compstatin With Peptide Backbone And C-Terminal Modifications
07/12/2012US20120178693 Cofactors for Thrombin Activation of Factor VII and Uses Thereof
07/12/2012US20120178692 Dosage forms of polymer-factor viii moiety conjugates
07/12/2012US20120178691 Factor viii compositions and methods of making and using same
07/12/2012US20120178690 Novel netrin derivatives and uses thereof
07/12/2012US20120178689 Methods of treatment with natriuretic peptides
07/12/2012US20120178688 Therapeutic agents for reducing parathyroid hormone levels
07/12/2012US20120178687 Suspension formulations of insulinotropic peptides and uses thereof
07/12/2012US20120178686 Chemical induction of lactation
07/12/2012US20120178685 Fgf21 mutants and uses thereof
07/12/2012US20120178684 Surgical Calcium Phosphate Citrate-Containing Cement and Method of Manufacturing the Same
07/12/2012US20120178683 Vegf antagonist formulations
07/12/2012US20120178682 GB1 Peptidic Compounds and Methods for Making and Using the Same
07/12/2012US20120178681 Bipiperidinyl compounds, compositions, containing such compounds and methods of treatment
07/12/2012US20120178680 Glycoside derivatives and uses thereof
07/12/2012US20120178679 Fused aromatic ptp-ib inhibitors
07/12/2012US20120178678 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors
07/12/2012US20120178677 Soft protease inhibitors, and pro-soft forms thereof
07/12/2012US20120178676 Pegylated c-peptide
07/12/2012US20120178675 Compositions And Methods For Modulating The Pharmacokinetics and Pharmacodynamics of Insulin
07/12/2012US20120178674 Mixture of non-digestible oligosaccharides for stimulating the immune system
07/12/2012US20120178673 Fat accumulation suppressor
07/12/2012US20120178672 Compositions and Methods for Sparing Muscle in Renal Insufficiency and During Hemodialysis
07/12/2012US20120178671 Inhibition of nfk-b mediated virus replication with specific oligosaccharides
07/12/2012US20120178670 Acylated glucagon analogues
07/12/2012US20120178669 Protease inhibitors, compositions and methods of use
07/12/2012US20120178668 Proteinaceous compounds and uses therefor
07/12/2012US20120178667 Methods for treating septic shock
07/12/2012US20120178666 Prodrugs of guanfacine
07/12/2012US20120178629 Apparatus and methods for preparing an emulsion
07/12/2012US20120178163 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
07/12/2012US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
07/12/2012US20120177744 Method of using beta-hydroxy-beta-methylbutyrate for the treatment of cancer
07/12/2012US20120177740 Drug delivery formulation for controlling of initial burst and manufacturing method thereof
07/12/2012US20120177737 High drug load tablet
07/12/2012US20120177726 Medical use of spla2 hydrolysable liposomes
07/12/2012US20120177722 Lyaseenzymes, Nucleic Acids Encoding Them and Methods For Making and Using Them
07/12/2012US20120177721 Formulation
07/12/2012US20120177720 Multi-layer wound dressings
07/12/2012US20120177719 Medical device intended to come into contact with a patient's tissue and related manufacturing method
07/12/2012US20120177718 Wound-covering material
07/12/2012US20120177717 Sustained drug delivery system
07/12/2012US20120177715 Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity
07/12/2012US20120177702 Solid Forms for Tissue Repair
07/12/2012US20120177699 Preparation Method of Drug Loaded Emulsion
07/12/2012US20120177697 Excipients In Drug Delivery Vehicles
07/12/2012US20120177695 Bioerodible Silicon-Based Devices for Delivery of Therapeutic Agents
07/12/2012US20120177692 Delivery systems for solubilising water-insoluble pharmaceutical active ingredients
07/12/2012US20120177676 Alphabodies for hiv entry inhibition
07/12/2012US20120177674 Compositions comprising fungal immunomodulatory protein and use thereof
07/12/2012US20120177667 Metal Abstraction Peptide (MAP) Tag and Associated Methods